Company Analysis
Sign in

Zura Bio Limited (ZURA)

Nasdaq: ZURA · Biological Products, (No Diagnostic Substances) · La Jolla, CA · filing with the SEC since 2021
Full chart Alerts Compare
Grade4.7
◀ Past 2.9● Present 3.9▶ Future 6.6
6 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021
Report filedMar 19, 2026Mar 25, 2025Mar 28, 2024Mar 28, 2023Apr 11, 2022
Research and development42,082,00024,401,00043,999,000··
General and administrative33,164,00030,788,00018,639,0002,294,039·
Total operating expenses75,246,00055,189,00062,638,000··
Operating income-75,246,000-55,189,000-62,638,000-2,675,141·
Interest and investment income6,336,0007,998,0002,186,000570·
Other income (expense), net··2,075,000··
Total non-operating income (expense)6,596,0002,786,0002,075,0006,224,268·
Income before income taxes-68,650,000-52,403,000-60,563,000··
Income tax expense·00··
Income from continuing operations·-52,403,000-60,563,000··
Net income including non-controlling interests-68,650,000-52,403,000-60,563,0003,549,127·
Net income-68,650,000-52,403,000-60,360,000-25,700,000r·
Net income to common shareholders-99,353,000-45,386,000-69,243,000··
Earnings per share, basic-1.06-0.60-2.09··
Earnings per share, diluted-1.06-0.60-2.09··
Weighted average shares, basic94,160,13875,070,76133,064,036··
Weighted average shares, diluted94,160,13875,070,76133,064,036··
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton ZURA · research, not advice